Online Exclusive | From the Member Sections | From the Sidelines to the Guidelines: A History of Palliative Care in the Heart Failure Guidelines
For patients living with heart failure (HF), novel therapeutics have become guideline-directed care, transforming clinical practice and improving patients’ lives. In parallel, cardiovascular clinicians increasingly recognize the value of palliative care (PC) for patients with serious cardiovascular illnesses…
Eagle’s Eye View: SPECIAL AHA RECAP focusing on seven studies: ZEUS & Ziltivekima; HORIZON & Pelacarsen; OPTIMAL-STROKE & BP Control; STREAM & Statin Therapy; OPTIMA-DIABETES & BP Control Through Yoga, OptimPacing & Left Bundle-Branch Pacing; COAST-AF & Ablation
n this special edition of the View, Dr. Eagle looks at seven studies presented at the recent American Heart Association Conference that could have immediate effects on your practice.
Incorporating the Lipid and Cardiometabolic Clinic into Practice: Tips and Tricks
This episode is part of ACC’s ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Explore key updates from the 2026 Guideline for the Treatment of Dyslipidemia with Drs. Eugenia Gianos and Michael Blaha, including connections to the 2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline.
JACC LAAC Special Issue: ASAP-TOO Five-Year Results, LAAC Evidence Review, More
A special issue of JACC published Thursday, Nov. 12, focuses on left atrial appendage closure (LAAC), presenting the most recent results from the ASAP-TOO trial, along with a JACC evidence review for LAAC vs. anticoagulation, and a number of analyses and viewpoints on current LAAC evidence, practice patterns and emerging clinical questions.
CMS Finalizes Ambulatory Specialty Model For HF Beginning January 2027
Despite multiple ACC requests for modifications or delay, the Centers for Medicare and Medicaid Services (CMS) declined to provide a transition or education period before implementation of the Ambulatory Specialty Model (ASM) for heart failure (HF). In the 2027 Medicare Physician Fee Schedule (PFS) final rule, released last week, CMS confirmed the model will begin its initial performance year on Jan. 1, 2027.
NCDR Research at AHA 2026: OAC After LAAO; PCI and tMCS in Patients With Ischemic Cardiomyopathy
Explore key findings from two AHA 2026 abstracts using NCDR registry data.
2027 Hospital OPPS Final Rule: Key Provisions
The Centers for Medicare and Medicaid Services (CMS) has issued the 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, finalizing a 2.3% increase to OPPS payment rates that reflects a market basket update of 3.2% reduced by a productivity adjustment of 0.9%.
ACCEL Lite: Results of the AFFIRMO Trial
In this episode, Thomas F. Deering MD, FACC and Gregory Y. H. Lip, MD, FACC discuss AFFIRMO: Atrial Fibrillation integrated approach in FraIl, multimoRbid and polyMedicated Older people.
AI in CV Diagnosis: From Smartwatch Screening to Faster Echo Interpretation
Two late-breaking studies presented at AHA 2026 highlight AI’s potential to extend cardiovascular screening and improve diagnostic workflow, while underscoring the continued importance of clinician oversight.
ATTAIN-OSA: Orforglipron For Severe OSA in Adults With Obesity or Overweight
Once-daily oral orforglipron improved moderate to severe obstructive sleep apnea (OSA) compared with placebo in adults with obesity or overweight, based on findings from the ATTAIN-OSA trial presented at AHA 2026 and simultaneously published in JAMA.
